Literature DB >> 25233870

2013 American College of Rheumatology/European League against rheumatism classification criteria for systemic sclerosis outperform the 1980 criteria: data from the Canadian Scleroderma Research Group.

Hebah Alhajeri1, Marie Hudson, Marvin Fritzler, Janet Pope, Solène Tatibouet, Janet Markland, David Robinson, Niall Jones, Nader Khalidi, Peter Docherty, Elzbieta Kaminska, Ariel Masetto, Evelyn Sutton, Jean-Pierre Mathieu, Sophie Ligier, Tamara Grodzicky, Sharon LeClercq, Carter Thorne, Geneviève Gyger, Douglas Smith, Paul R Fortin, Maggie Larché, Murray Baron.   

Abstract

OBJECTIVE: The goal of this study was to determine the sensitivity of the new 2013 classification criteria for systemic sclerosis (SSc; scleroderma) in an independent cohort of SSc subjects and to assess the contribution of individual items of the criteria to the overall sensitivity.
METHODS: SSc subjects from the Canadian Scleroderma Research Group cohort were assessed. Sensitivity was determined in several subgroups of patients. In patients without the criterion of skin thickening proximal to the metacarpophalangeal (MCP) joints, we recalculated sensitivity after removing the individual criterion.
RESULTS: A total of 724 SSc patients were included. Most were women (86%), mean age was 55.8 years, mean disease duration was 10.9 years, and 59% had limited cutaneous SSc (lcSSc). Overall, the sensitivity of the 2013 criteria was 98.3% compared to 88.3% for the 1980 criteria. This pattern was consistent among those with lcSSc (98.8% versus 85.6%), anticentromere antibodies (98.9% versus 79.8%), disease duration ≤3 years (98.7% versus 84.7%), and no skin involvement proximal to the MCP joints (97% versus 60%). In the latter subgroup, removing Raynaud's phenomenon and sclerodactyly from the criteria reduced the sensitivity to 77% and 79%, respectively. Removing both sclerodactyly and puffy fingers reduced the sensitivity to 62%.
CONCLUSION: The 2013 SSc classification criteria classify more SSc patients than the 1980 criteria. The improvement in sensitivity is most striking in those with lcSSc, especially those without skin involvement proximal to the MCP joints. The addition of Raynaud's phenomenon and puffy fingers to the 2013 criteria accounts for important gains in sensitivity.
Copyright © 2015 by the American College of Rheumatology.

Entities:  

Mesh:

Year:  2015        PMID: 25233870     DOI: 10.1002/acr.22451

Source DB:  PubMed          Journal:  Arthritis Care Res (Hoboken)        ISSN: 2151-464X            Impact factor:   4.794


  27 in total

1.  Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality.

Authors:  Nicolas Richard; Marie Hudson; Mianbo Wang; Geneviève Gyger; Susanna Proudman; Wendy Stevens; Mandana Nikpour; Murray Baron
Journal:  Rheumatology (Oxford)       Date:  2019-04-01       Impact factor: 7.580

2.  New ACR EULAR guidelines for systemic sclerosis classification.

Authors:  Sindhu R Johnson
Journal:  Curr Rheumatol Rep       Date:  2015-05       Impact factor: 4.592

3.  Connective tissue diseases: New criteria improve recognition of early systemic sclerosis.

Authors:  Yoshihide Asano; Shinichi Sato
Journal:  Nat Rev Rheumatol       Date:  2014-11-11       Impact factor: 20.543

Review 4.  Update on systemic sclerosis.

Authors:  Courtney J McCray; Maureen D Mayes
Journal:  Curr Allergy Asthma Rep       Date:  2015-05       Impact factor: 4.806

5.  Association between immunosuppressive therapy and course of mild interstitial lung disease in systemic sclerosis.

Authors:  Sabrina Hoa; Sasha Bernatsky; Russell J Steele; Murray Baron; Marie Hudson
Journal:  Rheumatology (Oxford)       Date:  2020-05-01       Impact factor: 7.580

6.  Antifibrillarin Antibodies Are Associated with Native North American Ethnicity and Poorer Survival in Systemic Sclerosis.

Authors:  Carolina Mejia Otero; Shervin Assassi; Marie Hudson; Maureen D Mayes; Rosa Estrada-Y-Martin; Claudia Pedroza; Tingting W Mills; Jennifer Walker; Murray Baron; Wendy Stevens; Susanna M Proudman; Mandana Nikpour; Sonal Mehra; Mianbo Wang; Marvin J Fritzler
Journal:  J Rheumatol       Date:  2017-04-01       Impact factor: 4.666

7.  Validation of the ACR/EULAR classification criteria for systemic sclerosis in patients with early scleroderma.

Authors:  Farley Carvalho Araújo; Cíntia Zumstein Camargo; Cristiane Kayser
Journal:  Rheumatol Int       Date:  2017-08-17       Impact factor: 2.631

8.  The association of sociodemographic and objectively-assessed disease variables with fatigue in systemic sclerosis: an analysis of 785 Canadian Scleroderma Research Group Registry patients.

Authors:  Brooke Levis; Linda Kwakkenbos; Marie Hudson; Murray Baron; Brett D Thombs
Journal:  Clin Rheumatol       Date:  2016-12-10       Impact factor: 2.980

9.  Performance of the new American College of Rheumatology classification criteria in Turkish systemic sclerosis patients: a multicenter study.

Authors:  Omer Nuri Pamuk; Mehmet Ali Balcı; Ahmet Mesut Onat; Orhan Zengin; Necati Cakır; Bunyamin Kısacık
Journal:  Clin Rheumatol       Date:  2015-12-07       Impact factor: 2.980

10.  Development and Validation of the Body Concealment Scale for Scleroderma.

Authors:  Lisa R Jewett; Vanessa L Malcarne; Linda Kwakkenbos; Diana Harcourt; Nichola Rumsey; Annett Körner; Russell J Steele; Marie Hudson; Murray Baron; Jennifer A Haythornthwaite; Leslie Heinberg; Fredrick M Wigley; Brett D Thombs
Journal:  Arthritis Care Res (Hoboken)       Date:  2016-08       Impact factor: 4.794

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.